Abstract: Provided is an indole compound. In particular, disclosed are a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof and a use of the same as an estrogen receptor antagonist in preparing a drug for treating estrogen receptor-positive breast cancer.

Abstract: A method for constructing a decoding network, a speech recognition method, a device, an apparatus, and a storage medium are provided. The method for constructing a decoding network includes: acquiring a general language model, a domain language model, and a general decoding network generated based on the general language model; generating a domain decoding network based on the domain language model and the general language model; and integrating the domain decoding network with the general decoding network to obtain a target decoding network. The speech recognition method includes: decoding to-be-recognized speech data by using a target decoding network to obtain a decoding path for the to-be-recognized speech data; and determining a speech recognition result for the to-be-recognized speech data based on the decoding path for the to-be-recognized speech data.

Abstract: A speech recognition error correction method and device, and a readable storage medium are provided. The method includes: acquiring to-be-recognized speech data and a first recognition result of the speech data, re-recognizing the speech data with reference to context information in the first recognition result to obtain a second recognition result, and determining a final recognition result based on the second recognition result. In the method, the speech data is re-recognized with reference to context information in the first recognition result, which fully considers context information in the recognition result and the application scenario of the speech data. If any error occurs in the first recognition result, the first recognition result is corrected based on the second recognition. Therefore, the accuracy of speech recognition can be improved.

Abstract: Preparation and application of a series of polypeptides, and specifically disclosed is a polypeptide having a sequence as shown in formula (II). YAibEGT FTSDY SIAibLD KIAQK AFVKW LIAGG PSSGA PPPS0??(II).

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Disclosed is an aminopyrimidine compound as a CDK2/4/6 inhibitor, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof, and an application of the compound represented by formula (I) and the pharmaceutically acceptable salt thereof in the preparation of a medicament for treating solid tumor.

Abstract: Disclosed in the present invention are a series of fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compounds and the use thereof. Specifically disclosed are a compound represented by formula (H) and a pharmaceutically acceptable salt thereof.

Abstract: A series of piperidine-substituted benzoic acid compounds and the use thereof, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Disclosed are a [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and an application thereof in preparing a drug for treating a disease related to JAK1 or/and TYK2. Specifically, the present invention relates to a compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof.

Abstract: A class of lactam-modified polypeptide compounds and the use thereof in the preparation of a drug for treating related diseases.

Abstract: Provided are a class of pyridone multiple-membered ring derivatives and the use thereof. Specifically provided are a compound as represented by formula (VI) and a pharmaceutically acceptable salt thereof.

Abstract: A crystal form of a pyridinylphenyl compound and a preparation method therefor. Use of the crystal form in the preparation of a medicament of treating related diseases is also comprised.

Abstract: Disclosed is a class of octahydropyrazinodiazanaphthyridine dione compounds, and specifically disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.

Abstract: The invention provides a parameters tuning method of energy storage system and the energy storage system, and the method comprises the following steps: using PID control module to construct a closed-loop control subsystem of energy dispatching; acquiring PID initial parameters according to the energy dispatching model of the energy storage system; setting an adaptive model in the PID control module, and processing the PID initial parameters through the adaptive model to obtain PID adjusted and modified parameters; using the PID adjusted and modified parameters to modify the PID parameters and get the PID tuning parameters. What's more, the system comprises a battery module, a bidirectional converter device, an energy dispatching subsystem and a closed-loop control subsystem; and the closed-loop control subsystem is provided with a PID control module, and the PID control module is provided with an adaptive model for realizing the parameters tuning method of the energy storage system.

Abstract: A pyrimidine ring compound represented by formula (III), or a pharmaceutically acceptable salt thereof, and an application thereof in preparation of a medication for treating related diseases.

Abstract: Disclosed are a class of BTK kinase inhibitor compounds with a high activity and a high selectivity and the use thereof in the preparation of a drug for treating BTK target-related diseases. Specifically, disclosed are a compound shown as formula (I), and an isomer and a pharmaceutically acceptable salt thereof.

Abstract: A novel indazole compound, a preparation method therefor, and use thereof in the preparation of drugs for treating related diseases. Specifically disclosed are a compound of formula (II) and a pharmaceutically acceptable salt thereof.

Abstract: A discourse-level text translation method and device, the method comprising: acquiring a text to be translated, the text to be translated being a unit text in a discourse-level text to be translated (S101); acquiring an associated text of the text to be translated, the associated text including at least one of a preceding source text, a following source text, and a preceding target text (S102); and translating, according to the associated text, the text to be translated (S103).

Abstract: The invention provides a parameters tuning method of energy storage system and the energy storage system, and the method comprises the following steps: using PID control module to construct a closed-loop control subsystem of energy dispatching; acquiring PID initial parameters according to the energy dispatching model of the energy storage system; setting an adaptive model in the PID control module, and processing the PID initial parameters through the adaptive model to obtain PID adjusted and modified parameters; using the PID adjusted and modified parameters to modify the PID parameters and get the PID tuning parameters. What's more, the system comprises a battery module, a bidirectional converter device, an energy dispatching subsystem and a closed-loop control subsystem; and the closed-loop control subsystem is provided with a PID control module, and the PID control module is provided with an adaptive model for realizing the parameters tuning method of the energy storage system.